摘要
Migraine is among the most prevalent and disabling neurological diseases in the world. Cortical spreading depression (SD) is an intense wave of neuronal and glial depolarization underlying migraine aura, and a headache trigger, which has been used as an experimental platform for drug screening in migraine. Here, we provide an overview of novel therapeutic targets that show promise to suppress SD, such as acid-sensing ion channels, casein kinase Iδ, P2X7-pannexin 1 complex, and neuromodulation, and outline the experimental models and essential quality measures for rigorous and reproducible efficacy testing.
| 原文 | English |
|---|---|
| 頁（從 - 到） | 1340-1358 |
| 頁數 | 19 |
| 期刊 | Headache |
| 卷 | 57 |
| 發行號 | 9 |
| DOIs | |
| 出版狀態 | Published - 10月 2017 |